Open navigation
Search
Search

Select your region

Daniel Mahn
Counsel

Daniel Mahn

Rechtsanwalt

Languages
  • German
  • English
Social media

Daniel Mahn advises strategic investors and private equity funds on domestic and cross border M&A transactions. He acts both for buyers and sellers and takes over project coordination. His practice also covers company incorporations and restructurings as well as general corporate law matters.

Daniel has specialized in healthcare M&A transactions (particularly MVZ transactions) and he advises clients regularly on the acquisition of (single or joint) medical practices, laboratories and clinics.

Daniel co-authored the publication "Getting the Deal Through Healthcare M&A" together with Dr Christoph Lächler and Dr Roland Wiring.

Daniel joined CMS in 2015. He has been teaching law at the University of Heidelberg since 2018.

Relevant experience

  • Seafort Advisors | Advice on the sale of VERTIKOM Group
  • PREMIUM Equity Partners | Advice on the acquisition of a majority share in CLARUS Films Group
  • NTT-DATA | Advice on the acquisition of gen-ius dms GmbH
  • NEXTCLINICS INTERNATIONAL GmbH | Advice on the acquisition of IVF-Zentren Prof. ZECH (group of private clinics)

Publications

  • “Getting the Deal Through: Healthcare M&A, Country Report Germany, September 2019, Law Business Research Ltd.” (together with Dr Roland Wiring und Dr Christoph Lächler)

Education

  • 2014: Second state examination in law
  • 2012 - 2014: Trainee lawyer at Stuttgart Regional Court
  • 2010 - 2012: Grading assistant at the University of Heidelberg
  • 2010: First state examination in law
  • 2004: Law studies at the University of Heidelberg

Insights by Daniel

CMS advises SYNLAB on the sale of synlab slovakia s.r.o. to Unilabs Group

11 Feb 2026 2 min read

CMS advises Sunrise Medical on the acquisition of Ergoflix Group

23 Jan 2026 2 min read

CMS advises Quartz Healthcare Germany on the Acquisition of MVZ Rheine in North Rhine-Westphalia

08 Oct 2025 2 min read

CMS advises Unigestion Private Equity on the acquisition of a stake in Ortivity Group

25 Aug 2025 2 min read
Back to top Back to top